FreeTheAI

Milestone Pharmaceuticals, Inc.

MIST · NASDAQ · USD

$0.7650

+0.0529 7.43%todayNot financial advice.

MIST Price chart 5D
Open
0.7200
Day range
0.7075 - 0.7740
52-week range
0.7075 - 3.06
Volume
1.22M
Market cap
95.24M
P/E ratio
—
EPS
-0.69
Dividend yield
0.00%
Beta
3.68

Performance

W

−6.24%

1M

−32.30%

3M

−41.15%

6M

−62.68%

YTD

−62.50%

Y

−61.94%

5Y

−86.09%

All

−95.10%

In the news

  1. Oct 9

    Milestone Pharmaceuticals Enrolls First European Patient in Phase 3 AFib Trial

    Milestone Pharmaceuticals enrolled its first European patient in a Phase 3 trial of its etripamil nasal spray for rapid heart rate conditions.

    Company news

  2. Oct 9

    Milestone Pharmaceuticals Advances Heart Drug Trial with First European Patient

    Milestone Pharmaceuticals has enrolled its first European patient in a Phase 3 study for an AFib-RVR nasal spray, which could reduce ER visits.

    Company news

Embed on your site

Embed docs

Add a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.

<iframe src="https://stocks.freetheai.org/embed/NASDAQ-MIST" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Milestone Pharmaceuticals, Inc. (MIST) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-MIST">MIST stock price</a> by FreeTheAI Stocks</p>